Cite
HARVARD Citation
Desai, M. et al. (2023). Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Circulation. 147 (11), pp. 850-863. [Online].